Last 12 months
Inside the activity.
3 purchase rows · 12 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 4 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 2 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 12, 2024 Filed Mar 13, 2024 20:37 UTC |
DURCAN DERMOT MARKDirector
|
GrantCommon Stock | 1,053 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-24-000046 · wk-form4_1710362234.xml · nonDerivative · entry 2 DURCAN DERMOT MARK · CIK 0001202358 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,376 F2 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of the grant. Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 20:35 UTC |
GOCHNAUER RICHARD WDirector
|
GrantCommon Stock | 843 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-24-000044 · wk-form4_1710362099.xml · nonDerivative · entry 2 GOCHNAUER RICHARD W · CIK 0001214315 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,762 F2 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of grant. Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 20:31 UTC |
GREENBERG LON RDirector
|
GrantCommon Stock | 843 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-24-000040 · wk-form4_1710361877.xml · nonDerivative · entry 1 GREENBERG LON R · CIK 0001234234 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,062 F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of grant. Receipt of shares deferred until 01/15/2026. Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 20:30 UTC |
NALLY DENNIS MDirector
|
GrantCommon Stock | 843 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-24-000039 · wk-form4_1710361815.xml · nonDerivative · entry 2 NALLY DENNIS M · CIK 0001685596 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,819 F2 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of grant. Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 20:18 UTC |
Baumann WernerDirector
|
GrantCommon Stock | 843 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-24-000036 · wk-form4_1710361123.xml · nonDerivative · entry 1 Baumann Werner · CIK 0001986505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,563 F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of grant. Receipt of shares deferred until 01/15/2028. Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 20:15 UTC |
Miller RedondaDirector
|
GrantCommon Stock | 843 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-24-000033 · wk-form4_1710360896.xml · nonDerivative · entry 1 Miller Redonda · CIK 0001891346 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,405 F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of grant. Delivery of vested shares deferred until 01/03/2029. Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 20:13 UTC |
Tyler Lauren MDirector
|
GrantCommon Stock | 843 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-24-000031 · wk-form4_1710360769.xml · nonDerivative · entry 1 Tyler Lauren M · CIK 0001765744 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,563 F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of grant. Delivery of vested shares deferred until 03/12/2026. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:33 UTC |
HYLE KATHLEEN WDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 1,593 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-24-000042 · wk-form4_1710361992.xml · derivative · entry 3 HYLE KATHLEEN W · CIK 0001117310 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,593 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Cencora, Inc. F3 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of Cencora, Inc. F4 · derivative.exercise_date: 2021 annual grant of restricted stock units received for no consideration and vested 100% on March 11, 2024. F4 · derivative.expiration_date: 2021 annual grant of restricted stock units received for no consideration and vested 100% on March 11, 2024. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:33 UTC |
HYLE KATHLEEN WDirector
|
Exercise / conversionCommon Stock | 1,593 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-24-000042 · wk-form4_1710361992.xml · nonDerivative · entry 1 HYLE KATHLEEN W · CIK 0001117310 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects the vesting of 2021 annual grant of restricted stock units described in Table II. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:43 UTC |
Battaglia SilvanaExecutive Vice President
|
GrantRestricted Stock Units · Derivative | 8,415 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-24-000052 · wk-form4_1710362578.xml · derivative · entry 1 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,415 Underlying: Common Stock · 8,415 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Cencora, Inc. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of Cencora, Inc. F2 · derivative.exercise_date: The restricted stock units will vest in full on March 11, 2026, which is the second anniversary of the grant date, subject to the reporting person's continued employment through such date. F2 · derivative.expiration_date: The restricted stock units will vest in full on March 11, 2026, which is the second anniversary of the grant date, subject to the reporting person's continued employment through such date. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:41 UTC |
Cleary James FChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 12,623 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-24-000050 · wk-form4_1710362478.xml · derivative · entry 1 Cleary James F · CIK 0001333281 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,623 Underlying: Common Stock · 12,623 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Cencora, Inc. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of Cencora, Inc. F2 · derivative.exercise_date: The restricted stock units will vest in full on March 11, 2026, which is the second anniversary of the grant date, subject to the reporting person's continued employment through such date. F2 · derivative.expiration_date: The restricted stock units will vest in full on March 11, 2026, which is the second anniversary of the grant date, subject to the reporting person's continued employment through such date. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:39 UTC |
Campbell Elizabeth SExecutive Vice President
|
GrantRestricted Stock Units · Derivative | 12,623 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-24-000048 · wk-form4_1710362358.xml · derivative · entry 1 Campbell Elizabeth S · CIK 0001882641 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,623 Underlying: Common Stock · 12,623 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Cencora, Inc. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of Cencora, Inc. F2 · derivative.exercise_date: The restricted stock units will vest in full on March 11, 2026, which is the second anniversary of the grant date, subject to the reporting person's continued employment through such date. F2 · derivative.expiration_date: The restricted stock units will vest in full on March 11, 2026, which is the second anniversary of the grant date, subject to the reporting person's continued employment through such date. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:37 UTC |
DURCAN DERMOT MARKDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 1,593 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-24-000046 · wk-form4_1710362234.xml · derivative · entry 3 DURCAN DERMOT MARK · CIK 0001202358 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,593 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Cencora, Inc. F3 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of Cencora, Inc. F4 · derivative.exercise_date: 2021 annual grant of restricted stock units received for no consideration and vested 100% on March 11, 2024. F4 · derivative.expiration_date: 2021 annual grant of restricted stock units received for no consideration and vested 100% on March 11, 2024. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:37 UTC |
DURCAN DERMOT MARKDirector
|
GrantCommon Stock | 1,593 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-24-000046 · wk-form4_1710362234.xml · nonDerivative · entry 1 DURCAN DERMOT MARK · CIK 0001202358 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,323 F1 · price: Reflects the vesting of 2021 annual grant of restricted stock units described in Table II. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:35 UTC |
GOCHNAUER RICHARD WDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 1,593 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-24-000044 · wk-form4_1710362099.xml · derivative · entry 3 GOCHNAUER RICHARD W · CIK 0001214315 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,593 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Cencora, Inc. F3 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of Cencora, Inc. F4 · derivative.exercise_date: 2021 annual grant of restricted stock units received for no consideration and vested 100% on March 11, 2024. F4 · derivative.expiration_date: 2021 annual grant of restricted stock units received for no consideration and vested 100% on March 11, 2024. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:35 UTC |
GOCHNAUER RICHARD WDirector
|
Exercise / conversionCommon Stock | 1,593 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-24-000044 · wk-form4_1710362099.xml · nonDerivative · entry 1 GOCHNAUER RICHARD W · CIK 0001214315 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,919 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects the vesting of 2021 annual grant of restricted stock units described in Table II. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:30 UTC |
NALLY DENNIS MDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 1,593 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-24-000039 · wk-form4_1710361815.xml · derivative · entry 3 NALLY DENNIS M · CIK 0001685596 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,593 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Cencora, Inc. F3 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of Cencora, Inc. F4 · derivative.exercise_date: 2021 annual grant of restricted stock units received for no consideration and vested 100% on March 11, 2024. F4 · derivative.expiration_date: 2021 annual grant of restricted stock units received for no consideration and vested 100% on March 11, 2024. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:30 UTC |
NALLY DENNIS MDirector
|
Exercise / conversionCommon Stock | 1,593 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-24-000039 · wk-form4_1710361815.xml · nonDerivative · entry 1 NALLY DENNIS M · CIK 0001685596 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,976 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects the vesting of 2021 annual grant of restricted stock units described in Table II. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:41 UTC |
Battaglia SilvanaExecutive Vice President
|
Exercise / conversionRestricted Stock Units · Derivative | 1,211 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-24-000029 · wk-form4_1710189656.xml · derivative · entry 3 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,211 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on March 9, 2022, March 9, 2023, and March 9, 2024. F1 · price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on March 9, 2022, March 9, 2023, and March 9, 2024. F1 · derivative.exercise_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on March 9, 2022, March 9, 2023, and March 9, 2024. F1 · derivative.expiration_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on March 9, 2022, March 9, 2023, and March 9, 2024. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:41 UTC |
Battaglia SilvanaExecutive Vice President
|
Tax withholdingCommon Stock | 537 | $237.47 | $127,521.39 |
DisclosureSEC source: 0001140859-24-000029 · wk-form4_1710189656.xml · nonDerivative · entry 2 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,354.803 Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:41 UTC |
Battaglia SilvanaExecutive Vice President
|
Exercise / conversionCommon Stock | 1,211 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-24-000029 · wk-form4_1710189656.xml · nonDerivative · entry 1 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,891.803 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on March 9, 2022, March 9, 2023, and March 9, 2024. Read SEC document |
| February 13, 2024 Filed Feb 14, 2024 21:14 UTC |
Clark GinaExecutive Vice President
|
SaleCommon Stock | 1,100 | $230.48 | $253,528.00 |
DisclosureSEC source: 0001140859-24-000027 · wk-form4_1707945265.xml · nonDerivative · entry 1 Clark Gina · CIK 0001625811 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,802 Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 12:00 UTC |
Walgreens Boots Alliance, Inc.10% owner
|
SaleCommon Stock | 4,212,395 | $235.41 | $991,639,906.95 |
DisclosureSEC source: 0000899243-24-000165 · doc4.xml · nonDerivative · entry 1 Walgreens Boots Alliance, Inc. · CIK 0001618921 · 10% owner Walgreens Boots Alliance Holdings LLC · CIK 0001669077 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 26,277,561 F4 · kind: Represents sale pursuant to Rule 144 (4,000,0000 shares) and a sale in private transaction to the Issuer (212,395 shares), in each case, by WBA Holdings. F1 · balance_after: As previously disclosed, including in the Schedule 13D filed by Walgreen Co. ("Walgreens") and others on April 15, 2014, as amended on January 16, 2015, January 25, 2016, March 22, 2016, August 25, 2016, November 14, 2016, January 6, 2021, June 3, 2021, May 12, 2022, August 4, 2022, November 9, 2022, December 12, 2022, May 15, 2023, June 20, 2023, August 7, 2023, November 14, 2023 and February 9, 2024 (the "Schedule 13D"), the Form 8-K filed by the Issuer on March 20, 2013, the Form 8-K filed by Walgreens on March 20, 2013, the Form 8-K filed by the Reporting Person on June 4, 2021 and the Form 8-K filed by the Issuer on June 2, 2021, the shares referenced in this Form 4 were acquired in accordance with the Framework Agreement, dated as of March 18, 2013 among Walgreens, Alliance Boots GmbH and the Issuer (the "Framework Agreement"). F1 · ownership.nature: As previously disclosed, including in the Schedule 13D filed by Walgreen Co. ("Walgreens") and others on April 15, 2014, as amended on January 16, 2015, January 25, 2016, March 22, 2016, August 25, 2016, November 14, 2016, January 6, 2021, June 3, 2021, May 12, 2022, August 4, 2022, November 9, 2022, December 12, 2022, May 15, 2023, June 20, 2023, August 7, 2023, November 14, 2023 and February 9, 2024 (the "Schedule 13D"), the Form 8-K filed by the Issuer on March 20, 2013, the Form 8-K filed by Walgreens on March 20, 2013, the Form 8-K filed by the Reporting Person on June 4, 2021 and the Form 8-K filed by the Issuer on June 2, 2021, the shares referenced in this Form 4 were acquired in accordance with the Framework Agreement, dated as of March 18, 2013 among Walgreens, Alliance Boots GmbH and the Issuer (the "Framework Agreement"). F2 · ownership.nature: These shares were held by Walgreens Boots Alliance Holdings LLC ("WBA Holdings"), an indirect wholly owned subsidiary of the Reporting Person. F3 · ownership.nature: As described in the Schedule 13D, WBA Investments, Inc., a direct wholly-owned subsidiary of the Reporting Person and the sole member of WBA Holdings, may also be deemed to beneficially own the securities reported in this Form 4. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 21:13 UTC |
NALLY DENNIS MDirector
|
GrantCommon Stock | 132 | $236.92 | $31,273.44 |
DisclosureSEC source: 0001140859-24-000025 · wk-form4_1707167573.xml · nonDerivative · entry 1 NALLY DENNIS M · CIK 0001685596 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,383 F1 · shares: Shares of common stock issued in lieu of $31,250 quarterly cash retainer per the terms of the Registrant's Non-Employee Director Compensation Program. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 21:10 UTC |
Baumann WernerDirector
|
GrantCommon Stock | 106 | $0.00 | $0.00 |
DisclosureSEC source: 0001140859-24-000023 · wk-form4_1707167427.xml · nonDerivative · entry 1 Baumann Werner · CIK 0001986505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 720 F1 · shares: Grant of Restricted Stock Units issued in lieu of $25,000 quarterly cash retainer per the Registrant's Non-Employee Director Compensation Program. Delivery of vested shares deferred until 01/15/2028. F1 · price: Grant of Restricted Stock Units issued in lieu of $25,000 quarterly cash retainer per the Registrant's Non-Employee Director Compensation Program. Delivery of vested shares deferred until 01/15/2028. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 21:08 UTC |
Tyler Lauren MDirector
|
GrantCommon Stock | 106 | $0.00 | $0.00 |
DisclosureSEC source: 0001140859-24-000021 · wk-form4_1707167311.xml · nonDerivative · entry 1 Tyler Lauren M · CIK 0001765744 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 720 F1 · shares: Grant of Restricted Stock Units received in lieu of $25,000 quarterly cash retainer per the Registrant's Non-Employee Director Compensation Program. Delivery of vested shares deferred until 03/01/2025. F1 · price: Grant of Restricted Stock Units received in lieu of $25,000 quarterly cash retainer per the Registrant's Non-Employee Director Compensation Program. Delivery of vested shares deferred until 03/01/2025. Read SEC document |
| January 15, 2024 Filed Jan 17, 2024 21:04 UTC |
GREENBERG LON RDirector
|
Exercise / conversionCommon Stock | 1,340 | $219.43 | $294,036.20 |
DisclosureSEC source: 0001140859-24-000014 · wk-form4_1705525458.xml · nonDerivative · entry 1 GREENBERG LON R · CIK 0001234234 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Annual grant of restricted stock units received for no consideration that previously vested 100% on March 1, 2021, the third anniversary of the date of grant. Receipt of these shares was deferred until January 15, 2024. Read SEC document |
| January 04, 2024 Filed Jan 8, 2024 21:12 UTC |
Battaglia SilvanaExecutive Vice President
|
GrantCommon Stock | 52.986 | $174.57 | $9,249.92 |
DisclosureSEC source: 0001140859-24-000008 · wk-form4_1704748350.xml · nonDerivative · entry 1 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,680.803 F1 · shares: Purchase of common stock through the Employee Stock Purchase Plan exempt under Rule 16b-3(c). Read SEC document |
| January 04, 2024 Filed Jan 8, 2024 21:10 UTC |
Campbell Elizabeth SExecutive Vice President
|
GrantCommon Stock | 57.569 | $174.57 | $10,049.99 |
DisclosureSEC source: 0001140859-24-000006 · wk-form4_1704748230.xml · nonDerivative · entry 1 Campbell Elizabeth S · CIK 0001882641 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,223.42 F1 · shares: Purchase of common stock through the Employee Stock Purchase Plan exempt under Rule 16b-3(c). Read SEC document |
| January 04, 2024 Filed Jan 8, 2024 21:09 UTC |
Donato Leslie EEVP & Chief Strategy Officer
|
GrantCommon Stock | 40.097 | $174.57 | $6,999.85 |
DisclosureSEC source: 0001140859-24-000004 · wk-form4_1704748133.xml · nonDerivative · entry 1 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,558.849 F1 · shares: Purchase of common stock through the Employee Stock Purchase Plan exempt under Rule 16b-3(c). Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 21:10 UTC |
Krikorian LazarusSVP & Chief Accounting Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 252 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140859-24-000002 · wk-form4_1704402590.xml · derivative · entry 3 Krikorian Lazarus · CIK 0001627534 · SVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 252 Underlying: Common Stock · 252 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Grant of restricted stock units received for no consideration that vest in three equal installments on 01/03/2023, 01/03/2024, and 01/03/2025. F1 · derivative.exercise_date: Grant of restricted stock units received for no consideration that vest in three equal installments on 01/03/2023, 01/03/2024, and 01/03/2025. F1 · derivative.expiration_date: Grant of restricted stock units received for no consideration that vest in three equal installments on 01/03/2023, 01/03/2024, and 01/03/2025. Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 21:10 UTC |
Krikorian LazarusSVP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 86 | $210.33 | $18,088.38 |
DisclosureSEC source: 0001140859-24-000002 · wk-form4_1704402590.xml · nonDerivative · entry 2 Krikorian Lazarus · CIK 0001627534 · SVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,042 Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 21:10 UTC |
Krikorian LazarusSVP & Chief Accounting Officer
|
Exercise / conversionCommon Stock | 252 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-24-000002 · wk-form4_1704402590.xml · nonDerivative · entry 1 Krikorian Lazarus · CIK 0001627534 · SVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,128 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Grant of restricted stock units received for no consideration that vest in three equal installments on 01/03/2023, 01/03/2024, and 01/03/2025. Read SEC document |
| December 21, 2023 Filed Dec 26, 2023 21:00 UTC |
Donato Leslie EEVP & Chief Strategy Officer
|
SaleCommon Stock | 3,400 | $202.13 | $687,242.00 |
DisclosureSEC source: 0001140859-23-000217 · wk-form4_1703624417.xml · nonDerivative · entry 1 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,518.752 Read SEC document |
| December 15, 2023 Filed Dec 18, 2023 21:09 UTC |
COLLIS STEVEN HDirector · Chairman, President & CEO
|
GiftCommon Stock | 3,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001140859-23-000215 · wk-form4_1702933777.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 285,088 F1 · shares: On December 15, 2023, the reporting person donated 3,600 shares of directly owned shares of common stock to a donor-advised fund, which will use the gifted shares for charitable purposes. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 21:22 UTC |
COLLIS STEVEN HDirector · Chairman, President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 1,015 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140859-23-000213 · wk-form4_1702675367.xml · derivative · entry 4 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,393 Underlying: Common Stock · 1,015 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Grant of restricted stock units received on 11/08/2023 for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026. F3 · shares: Reflects partial lapsing of restrictions on installment scheduled to vest on 11/08/2024 to cover FICA obligation and associated income taxes for retirement eligible employees on 2023 grant of restricted stock units. F2 · derivative.exercise_date: Grant of restricted stock units received on 11/08/2023 for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026. F2 · derivative.expiration_date: Grant of restricted stock units received on 11/08/2023 for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 21:22 UTC |
COLLIS STEVEN HDirector · Chairman, President & CEO
|
Tax withholdingCommon Stock | 1,015 | $203.72 | $206,775.80 |
DisclosureSEC source: 0001140859-23-000213 · wk-form4_1702675367.xml · nonDerivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 288,688 F3 · kind: Reflects partial lapsing of restrictions on installment scheduled to vest on 11/08/2024 to cover FICA obligation and associated income taxes for retirement eligible employees on 2023 grant of restricted stock units. F4 · price: The closing price of the Company's common stock on 12/13/2023, the date used to calculate the FICA tax obligation in accordance with IRS rules. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 21:22 UTC |
COLLIS STEVEN HDirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 1,015 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-23-000213 · wk-form4_1702675367.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 289,703 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Grant of restricted stock units received on 11/08/2023 for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 21:22 UTC |
COLLIS STEVEN HDirector · Chairman, President & CEO
|
SaleCommon Stock | 42,885 | $203.18 | $8,713,374.30 |
DisclosureSEC source: 0001140859-23-000213 · wk-form4_1702675367.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 288,688 F1 · price: The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $203.00 to $203.62 inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 21:21 UTC |
Campbell Elizabeth SExecutive Vice President
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 5,162 | $0.00 Strike: $89.58 | $0.00 |
DisclosureSEC source: 0001140859-23-000211 · wk-form4_1702675268.xml · derivative · entry 3 Campbell Elizabeth S · CIK 0001882641 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,162 shares Expires 2025-11-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/14/19, 11/14/20, 11/14/21 and 11/14/22. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 21:21 UTC |
Campbell Elizabeth SExecutive Vice President
|
SaleCommon Stock | 5,162 | $203.13 | $1,048,577.71 |
DisclosureSEC source: 0001140859-23-000211 · wk-form4_1702675268.xml · nonDerivative · entry 2 Campbell Elizabeth S · CIK 0001882641 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,165.851 F1 · price: The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $202.910 to $203.300 inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 21:21 UTC |
Campbell Elizabeth SExecutive Vice President
|
Exercise / conversionCommon Stock | 5,162 | $89.58 | $462,411.96 |
DisclosureSEC source: 0001140859-23-000211 · wk-form4_1702675268.xml · nonDerivative · entry 1 Campbell Elizabeth S · CIK 0001882641 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,327.851 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 21:19 UTC |
Cleary James FChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 307 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140859-23-000209 · wk-form4_1702675168.xml · derivative · entry 3 Cleary James F · CIK 0001333281 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,011 Underlying: Common Stock · 307 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Grant of restricted stock units received on 11/08/2023 for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026. F2 · shares: Reflects partial lapsing of restrictions on installment scheduled to vest on 11/8/2024 to cover FICA obligation and associated income taxes for retirement eligible employees on 2023 grant of restricted stock units. F1 · derivative.exercise_date: Grant of restricted stock units received on 11/08/2023 for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026. F1 · derivative.expiration_date: Grant of restricted stock units received on 11/08/2023 for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 21:19 UTC |
Cleary James FChief Financial Officer
|
Tax withholdingCommon Stock | 307 | $203.72 | $62,542.04 |
DisclosureSEC source: 0001140859-23-000209 · wk-form4_1702675168.xml · nonDerivative · entry 2 Cleary James F · CIK 0001333281 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,066.3479 F2 · kind: Reflects partial lapsing of restrictions on installment scheduled to vest on 11/8/2024 to cover FICA obligation and associated income taxes for retirement eligible employees on 2023 grant of restricted stock units. F3 · price: The closing price of the Company's common stock on 12/13/2023, the date used to calculate the FICA tax obligation in accordance with IRS rules. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 21:19 UTC |
Cleary James FChief Financial Officer
|
Exercise / conversionCommon Stock | 307 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-23-000209 · wk-form4_1702675168.xml · nonDerivative · entry 1 Cleary James F · CIK 0001333281 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,373.3479 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Grant of restricted stock units received on 11/08/2023 for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 21:17 UTC |
Mauch Robert P.Executive Vice President & COO
|
Exercise / conversionRestricted Stock Units · Derivative | 487 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140859-23-000207 · wk-form4_1702675071.xml · derivative · entry 3 Mauch Robert P. · CIK 0001633897 · Executive Vice President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,709 Underlying: Common Stock · 487 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Grant of restricted stock units received on 11/08/2023 for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026. F2 · shares: Reflects partial lapsing of restrictions on installment scheduled to vest on 11/08/2024 to cover FICA obligation and associated income taxes for retirement eligible employees on 2023 grant of restricted stock units. F1 · derivative.exercise_date: Grant of restricted stock units received on 11/08/2023 for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026. F1 · derivative.expiration_date: Grant of restricted stock units received on 11/08/2023 for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 21:17 UTC |
Mauch Robert P.Executive Vice President & COO
|
Tax withholdingCommon Stock | 487 | $203.72 | $99,211.64 |
DisclosureSEC source: 0001140859-23-000207 · wk-form4_1702675071.xml · nonDerivative · entry 2 Mauch Robert P. · CIK 0001633897 · Executive Vice President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,099 F2 · kind: Reflects partial lapsing of restrictions on installment scheduled to vest on 11/08/2024 to cover FICA obligation and associated income taxes for retirement eligible employees on 2023 grant of restricted stock units. F3 · price: The closing price of the Company's common stock on 12/13/2023, the date used to calculate the FICA tax obligation in accordance with IRS rules. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 21:17 UTC |
Mauch Robert P.Executive Vice President & COO
|
Exercise / conversionCommon Stock | 487 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-23-000207 · wk-form4_1702675071.xml · nonDerivative · entry 1 Mauch Robert P. · CIK 0001633897 · Executive Vice President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,586 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Grant of restricted stock units received on 11/08/2023 for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 21:16 UTC |
Clark GinaExecutive Vice President
|
Exercise / conversionRestricted Stock Units · Derivative | 137 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140859-23-000205 · wk-form4_1702674962.xml · derivative · entry 3 Clark Gina · CIK 0001625811 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,116 Underlying: Common Stock · 137 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Grant of restricted stock units received on 11/08/2023 for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026. F2 · shares: Reflects partial lapsing of restrictions on installment scheduled to vest on 11/08/2024 to cover FICA obligations and associated income taxes for retirement eligible employees on 2023 grant of restricted stock units. F1 · derivative.exercise_date: Grant of restricted stock units received on 11/08/2023 for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026. F1 · derivative.expiration_date: Grant of restricted stock units received on 11/08/2023 for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 21:16 UTC |
Clark GinaExecutive Vice President
|
Tax withholdingCommon Stock | 137 | $203.72 | $27,909.64 |
DisclosureSEC source: 0001140859-23-000205 · wk-form4_1702674962.xml · nonDerivative · entry 2 Clark Gina · CIK 0001625811 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,902 F2 · kind: Reflects partial lapsing of restrictions on installment scheduled to vest on 11/08/2024 to cover FICA obligations and associated income taxes for retirement eligible employees on 2023 grant of restricted stock units. F3 · price: The closing price of the Company's common stock on 12/13/2023, the date used to calculate the FICA tax obligation in accordance with IRS rules. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.